EYLEA 40MG/ML INJECTION

The frequency of EYLEA 40MG/ML INJECTION will depend on the specific condition being treated and the patient's response to treatment. For wet AMD, patients typically receive an initial round of injections followed by regular maintenance injections every 4 to 8 weeks.

Yes, receiving EYLEA 40MG/ML INJECTION will not correct refractive errors or cure any underlying eye conditions that may require corrective lenses. Patients should continue to use any prescribed eyeglasses or contact lenses as directed by their healthcare provider.

Yes, local anesthesia may be used before the EYLEA 40MG/ML INJECTION to help reduce pain and discomfort before the procedure. The anesthesia type will depend on the patient's needs and the healthcare provider's preferences.

While rare, there is a small risk of eye infections associated with EYLEA 40MG/ML INJECTION. Patients should report any symptoms of eye infection, such as redness, swelling, pain, or discharge, to their healthcare provider immediately.

Yes, you can still receive EYLEA 40MG/ML INJECTION if you have high blood pressure. However, it is important to inform your healthcare provider of any existing medical conditions, including high blood pressure, before starting treatment with EYLEA 40MG/ML INJECTION. This is because some patients may experience increased blood pressure as a side effect of the medication.

If you have kidney problems, informing your healthcare provider before starting treatment with EYLEA 40MG/ML INJECTION is important. While EYLEA 40MG/ML INJECTION is primarily used to treat eye conditions and does not have a direct effect on the kidneys, the medication is cleared from the body through the kidneys. Therefore caution may be needed in patients with impaired kidney function.

It is important to inform your healthcare provider about all the medications you are currently taking, including prescription, over-the-counter drugs, and herbal supplements, before starting treatment with EYLEA 40MG/ML INJECTION. Your doctor can assess potential interactions and ensure the safe use of this medication.

If you are currently being treated with EYLEA 40MG/ML INJECTION, it is crucial to notify your healthcare provider immediately if you feel any side effects or have any concerns. For pregnant individuals planning to conceive or breastfeeding, it is essential to consult with your healthcare provider to discuss the potential risks and benefits associated with the treatment. Patients with diabetic retinopathy should be closely monitored during treatment because this medication can worsen the condition. If you experience symptoms such as eye pain, worsening redness of the eye, reduced or blurry vision, or increased sensitivity to light while undergoing treatment, inform your doctor promptly. Lifestyle changes, including quitting smoking, maintaining a healthy weight, and following a healthy diet, can improve overall health and reduce the risk of cancer-related complications. Emotional support from family, friends, or support groups can help cancer patients manage their treatment challenges.

The active ingredient in EYLEA 40MG/ML INJECTION is Aflibercept.